Oct 19 (Reuters) -
* Crispr Therapeutics AG shares open at $15 in debut, above IPO price of $14 per share Further company coverage:
0 comments
Hide comments
Oct 19 (Reuters) -
* Crispr Therapeutics AG shares open at $15 in debut, above IPO price of $14 per share Further company coverage: